Mutational survivorship bias: The case of PNKP

Por um escritor misterioso

Descrição

The molecular function of a protein relies on its structure. Understanding how variants alter structure and function in multidomain proteins is key to elucidate the generation of a pathological phenotype. However, one may fall into the logical bias of assessing protein damage only based on the variants that are visible (survivorship bias), which can lead to partial conclusions. This is the case of PNKP, an important nuclear and mitochondrial DNA repair enzyme with both kinase and phosphatase function. Most variants in PNKP are confined to the kinase domain, leading to a pathological spectrum of three apparently distinct clinical entities. Since proteins and domains may have a different tolerability to variation, we evaluated whether variants in PNKP are under survivorship bias. Here, we provide the evidence that supports a higher tolerance in the kinase domain even when all variants reported are deleterious. Instead, the phosphatase domain is less tolerant due to its lower variant rates, a higher degree of sequence conservation, lower dN/dS ratios, and the presence of more disease-propensity hotspots. Together, our results support previous experimental evidence that demonstrated that the phosphatase domain is functionally more necessary and relevant for DNA repair, especially in the context of the development of the central nervous system. Finally, we propose the term "Wald’s domain" for future studies analyzing the possible survivorship bias in multidomain proteins.
Mutational survivorship bias: The case of PNKP
IJMS, Free Full-Text
Mutational survivorship bias: The case of PNKP
Browse Preprints - Authorea
Mutational survivorship bias: The case of PNKP
Species variations in XRCC1 recruitment strategies for FHA domain-containing proteins - ScienceDirect
Mutational survivorship bias: The case of PNKP
PNKP - an overview ScienceDirect Topics
Mutational survivorship bias: The case of PNKP
Browse Preprints - Authorea
Mutational survivorship bias: The case of PNKP
Species variations in XRCC1 recruitment strategies for FHA domain-containing proteins - ScienceDirect
Mutational survivorship bias: The case of PNKP
LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma, Hereditas
Mutational survivorship bias: The case of PNKP
Mutations of the DNA repair gene PNKP in a patient with microcephaly, seizures, and developmental delay (MCSZ) presenting with a high-grade brain tumor
Mutational survivorship bias: The case of PNKP
Mutational survivorship bias: The case of PNKP
Mutational survivorship bias: The case of PNKP
Phosphorylation of PNKP mediated by CDKs promotes end-processing of Okazaki fragments during DNA replication
Mutational survivorship bias: The case of PNKP
Thyroid Cancer and SNPs
Mutational survivorship bias: The case of PNKP
Mutational Survivorship Bias: The case of PNKP
Mutational survivorship bias: The case of PNKP
Importance of the PNKP DNA 5 -kinase, 3 -phosphatase, and FHA Domains
Mutational survivorship bias: The case of PNKP
Frontiers Juvenile Huntington's Disease and Other PolyQ Diseases, Update on Neurodevelopmental Character and Comparative Bioinformatic Review of Transcriptomic and Proteomic Data
Mutational survivorship bias: The case of PNKP
WWOX-related encephalopathies: delineation of the phenotypical spectrum and emerging genotype-phenotype correlation
de por adulto (o preço varia de acordo com o tamanho do grupo)